Inactivation of MAP3K7 in FOXD1-expressing cells results in loss of mesangial PDGFRΒ and juvenile kidney scarring.
Document Type
Article
Publication Date
8-1-2018
Institution/Department
Maine Medical Center Research Institute, Center for Molecular Medicine
Journal Title
American journal of physiology. Renal physiology
MeSH Headings
Animals, Cells, Cultured, Collagen Type IV, Disease Models, Animal, Enzyme Activation, Fibrosis, Forkhead Transcription Factors, Gene Silencing, Genetic Predisposition to Disease, Glomerulonephritis, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase Kinases, Mesangial Cells, Mice, Inbred C57BL, Mice, Knockout, Phenotype, Receptor, Platelet-Derived Growth Factor beta, Signal Transduction, p38 Mitogen-Activated Protein Kinases
Abstract
Transforming growth factor-β (TGFβ) plays a central role in renal scarring, controlling extracellular matrix deposition by interstitial cells and mesangial cells. TGFβ signals through Smad and mitogen-activated protein kinase (MAPK) pathways. To understand the role of MAPK in interstitial and mesangial cells, we genetically inactivated TGFβ-activated kinase-1 ( Map3k7) using Foxd1
ISSN
1522-1466
First Page
336
Last Page
336
Recommended Citation
Karolak, Michele J; Guay, Justin A; and Oxburgh, Leif, "Inactivation of MAP3K7 in FOXD1-expressing cells results in loss of mesangial PDGFRΒ and juvenile kidney scarring." (2018). Maine Medical Center. 1436.
https://knowledgeconnection.mainehealth.org/mmc/1436
